Virginia Rossi
Pisa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Identification and in-depth characterization of clinical isolates of Peribacillus frigoritolerans.
Journal: Microbiology spectrum
Published: July 15, 2026
Embarking on a new era in high-risk biochemical recurrent prostate cancer: redefining early systemic intervention.
Journal: Pharmacology & therapeutics
Published: April 28, 2026
Clinical and pathological predictors of early recurrence after neoadjuvant cisplatin gemcitabine in muscle invasive bladder cancer in the RealBLADDER study.
Journal: Scientific reports
Published: April 06, 2026
Predicting efficacy in patients with locally advanced/metastatic urothelial carcinoma (mUC) treated with immunotherapy using explainable machine learning approaches: the SamUR-AI trial on behalf of the Meet-URO group.
Journal: ESMO real world data and digital oncology
Published: April 03, 2026
Immune Checkpoint Inhibitor-Related Pneumonitis in Renal Cell Carcinoma: Clinical Features, Mechanisms, and Lessons from Lung Cancer.
Journal: Biomolecules
Published: March 06, 2026
Effectiveness and safety of avelumab maintenance in patients aged ≥75 years with advanced urothelial cancer: a sub-analysis of the meet-URO 25 (MALVA) study.
Journal: Frontiers in immunology
Published: February 26, 2026
Case Report: Niraparib-abiraterone in HRR-mutated metastatic castration-resistant prostate cancer: clinical insights from five cases.
Journal: Frontiers in oncology
Published: January 29, 2026
Therapeutic sequencing and role of cabozantinib after immunotherapy in metastatic renal cell carcinoma.
Journal: Critical reviews in oncology/hematology
Published: January 21, 2026
Concomitant medications and survival outcomes in patients receiving avelumab maintenance for advanced urothelial carcinoma: sub analysis of Meet-URO 25 study.
Journal: Clinical genitourinary cancer
Published: January 14, 2026
Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25.
Journal: Cancer immunology, immunotherapy : CII
Published: October 14, 2025
Overlapping Extremes: An Analysis of Avelumab Maintenance and Pembrolizumab in Advanced Urothelial Carcinoma.
Journal: Oncology and therapy
Published: August 29, 2025
A Snapshot from the Italian Clinical Practice Regarding Efficacy and Utility Rate of Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: The RealBLADDER Study.
Journal: In vivo (Athens, Greece)
Published: August 09, 2025
Last Updated: 09/26/2026